"Global Organ Preservation Solutions Market Overview:
Global Organ Preservation Solutions Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Organ Preservation Solutions Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Organ Preservation Solutions involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Organ Preservation Solutions Market:
The Organ Preservation Solutions Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Organ Preservation Solutions Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Organ Preservation Solutions Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Organ Preservation Solutions market has been segmented into:
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Application, Organ Preservation Solutions market has been segmented into:
Hypothermic Perfusion Preservation
Static Cold Storage
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Organ Preservation Solutions market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Organ Preservation Solutions market.
Top Key Players Covered in Organ Preservation Solutions market are:
Teva Pharmaceutical Industries Ltd.
Dr. Franz Köhler Chemie GmbH
BioLife Solutions
XVIVO Perfusion AB
Bristol-Myers Squibbinc.
ToleroTechinc.
Lifeline Scientific
Preservation Solutions Inc.
Claris Injectables Limited
21st Century Medicine
Paragonix Technologies Inc.
BioTimeinc. CryoLifeinc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Organ Preservation Solutions Market by Type
4.1 Organ Preservation Solutions Market Snapshot and Growth Engine
4.2 Organ Preservation Solutions Market Overview
4.3 Viaspan
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Viaspan: Geographic Segmentation Analysis
4.4 Custodiol HTK
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Custodiol HTK: Geographic Segmentation Analysis
4.5 Renograf
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Renograf: Geographic Segmentation Analysis
4.6 Hypothermosol
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Hypothermosol: Geographic Segmentation Analysis
4.7 Perfadex
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Perfadex: Geographic Segmentation Analysis
4.8 Lifor
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Lifor: Geographic Segmentation Analysis
4.9 HBS Solution
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 HBS Solution: Geographic Segmentation Analysis
4.10 siRNA Transplant Solutions
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 siRNA Transplant Solutions: Geographic Segmentation Analysis
4.11 Others
4.11.1 Introduction and Market Overview
4.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.11.3 Key Market Trends, Growth Factors and Opportunities
4.11.4 Others: Geographic Segmentation Analysis
Chapter 5: Organ Preservation Solutions Market by Application
5.1 Organ Preservation Solutions Market Snapshot and Growth Engine
5.2 Organ Preservation Solutions Market Overview
5.3 Hypothermic Perfusion Preservation
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hypothermic Perfusion Preservation: Geographic Segmentation Analysis
5.4 Static Cold Storage
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Static Cold Storage: Geographic Segmentation Analysis
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Organ Preservation Solutions Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 DR. FRANZ KÖHLER CHEMIE GMBH
6.4 BIOLIFE SOLUTIONS
6.5 XVIVO PERFUSION AB
6.6 BRISTOL-MYERS SQUIBBINC.
6.7 AND TOLEROTECHINC.
6.8 LIFELINE SCIENTIFIC
6.9 PRESERVATION SOLUTIONS INC.
6.10 CLARIS INJECTABLES LIMITED
6.11 21ST CENTURY MEDICINE
6.12 PARAGONIX TECHNOLOGIES INC.
6.13 BIOTIMEINC. CRYOLIFEINC.
Chapter 7: Global Organ Preservation Solutions Market By Region
7.1 Overview
7.2. North America Organ Preservation Solutions Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Viaspan
7.2.4.2 Custodiol HTK
7.2.4.3 Renograf
7.2.4.4 Hypothermosol
7.2.4.5 Perfadex
7.2.4.6 Lifor
7.2.4.7 HBS Solution
7.2.4.8 siRNA Transplant Solutions
7.2.4.9 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Hypothermic Perfusion Preservation
7.2.5.2 Static Cold Storage
7.2.5.3 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Organ Preservation Solutions Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Viaspan
7.3.4.2 Custodiol HTK
7.3.4.3 Renograf
7.3.4.4 Hypothermosol
7.3.4.5 Perfadex
7.3.4.6 Lifor
7.3.4.7 HBS Solution
7.3.4.8 siRNA Transplant Solutions
7.3.4.9 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Hypothermic Perfusion Preservation
7.3.5.2 Static Cold Storage
7.3.5.3 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Organ Preservation Solutions Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Viaspan
7.4.4.2 Custodiol HTK
7.4.4.3 Renograf
7.4.4.4 Hypothermosol
7.4.4.5 Perfadex
7.4.4.6 Lifor
7.4.4.7 HBS Solution
7.4.4.8 siRNA Transplant Solutions
7.4.4.9 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Hypothermic Perfusion Preservation
7.4.5.2 Static Cold Storage
7.4.5.3 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Organ Preservation Solutions Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Viaspan
7.5.4.2 Custodiol HTK
7.5.4.3 Renograf
7.5.4.4 Hypothermosol
7.5.4.5 Perfadex
7.5.4.6 Lifor
7.5.4.7 HBS Solution
7.5.4.8 siRNA Transplant Solutions
7.5.4.9 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Hypothermic Perfusion Preservation
7.5.5.2 Static Cold Storage
7.5.5.3 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Organ Preservation Solutions Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Viaspan
7.6.4.2 Custodiol HTK
7.6.4.3 Renograf
7.6.4.4 Hypothermosol
7.6.4.5 Perfadex
7.6.4.6 Lifor
7.6.4.7 HBS Solution
7.6.4.8 siRNA Transplant Solutions
7.6.4.9 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Hypothermic Perfusion Preservation
7.6.5.2 Static Cold Storage
7.6.5.3 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Organ Preservation Solutions Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Viaspan
7.7.4.2 Custodiol HTK
7.7.4.3 Renograf
7.7.4.4 Hypothermosol
7.7.4.5 Perfadex
7.7.4.6 Lifor
7.7.4.7 HBS Solution
7.7.4.8 siRNA Transplant Solutions
7.7.4.9 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Hypothermic Perfusion Preservation
7.7.5.2 Static Cold Storage
7.7.5.3 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Organ Preservation Solutions Scope:
|
Report Data
|
Organ Preservation Solutions Market
|
|
Organ Preservation Solutions Market Size in 2025
|
USD XX million
|
|
Organ Preservation Solutions CAGR 2025 - 2032
|
XX%
|
|
Organ Preservation Solutions Base Year
|
2024
|
|
Organ Preservation Solutions Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibbinc., and ToleroTechinc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTimeinc. CryoLifeinc..
|
|
Key Segments
|
By Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Applications
Hypothermic Perfusion Preservation
Static Cold Storage
Others
|
